Glycoprotein 100

Glycoprotein 100, gp100 or Melanocyte protein PMEL is 661 amino acids long and is a type I transmembrane glycoprotein enriched in melanosomes, which are the melanin-producing organelles in melanocytes. This protein is involved in melanosome maturation.

The gp100 protein is a melanoma antigen i.e. a tumor-associated antigen.

Short fragments of it have been used to develop the gp100 cancer vaccine which is or contains gp100:209-217(210M).^[1]

Hydrophilic recombinant gp100 protein (HR-gp100) has been topically applied on human intact skin in vitro, and used as a vaccine in a mouse model. It was demonstrated that HR-gp100 permeates into human skin, and is processed and presented by human dendritic cells. In the mouse model, an HR-gp100-based vaccine triggered antigen-specific T cell responses, as shown by proliferation assays, ELISA and intracellular staining for IFN-γ.

References

↑ http://www.cancer.gov/drugdictionary/?CdrID=476335

Eisenberg, G; Machlenkin, A; Frankenburg, S; Mansura, A; Pitcovski, J; Yefenof, E; Peretz, T; Lotem, M.Sharett (2010). "Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response". Cell Immunol 266 (1): 98–103. doi:10.1016/j.cellimm.2010.09.003.

This article is issued from Wikipedia - version of the Thursday, June 25, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.